Biotech | March 12, 2024
USFDA grants Orphan Drug Designation for iOnctura's first-in-class autotaxin cancer therapy
It is the first autotaxin inhibitor to be investigated in cancer patients
It is the first autotaxin inhibitor to be investigated in cancer patients
Vision loss due to Glaucoma can be prevented if it is detected and treated early
Women emerge as the cornerstone of this monumental undertaking
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
The investment will catalyse various components of the IndiaAI Mission
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
ANVISA issues CGMP to Concord Biotech’s Unit I
Nectar Lifesciences has clarified that the company has no relation/connection/ association or link of any nature with the Nectar Herbs and Drugs
Subscribe To Our Newsletter & Stay Updated
